These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15138927)

  • 41. Cytokeratins and the evaluation of tumor differentiation in squamous lesions of the uterine cervix.
    Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
    Gen Diagn Pathol; 1997 Jul; 143(1):15-22. PubMed ID: 9269904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
    Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunohistochemical localization of keratin and secretory component in carcinoma of the uterine cervix].
    Toki T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):359-64. PubMed ID: 2580030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. γH2Ax Expression as a Potential Biomarker Differentiating between Low and High Grade Cervical Squamous Intraepithelial Lesions (SIL) and High Risk HPV Related SIL.
    Leventakos K; Tsiodras S; Kelesidis T; Kefala M; Kottaridi C; Spathis A; Gouloumi AR; Pouliakis A; Pappas A; Sioulas V; Chrelias C; Karakitsos P; Panayiotides I
    PLoS One; 2017; 12(1):e0170626. PubMed ID: 28118377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia.
    Smedts F; Ramaekers F; Troyanovsky S; Pruszczynski M; Robben H; Lane B; Leigh I; Plantema F; Vooijs P
    Am J Pathol; 1992 Mar; 140(3):601-12. PubMed ID: 1372156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunocytochemical localization of keratin in normal, dysplastic and neoplastic cervical epithelium.
    Bychkov V; Chejfec G
    Gynecol Obstet Invest; 1984; 18(1):1-5. PubMed ID: 6204913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fas-mediated pathway and apoptosis in normal cervix, cervical intraepithelial neoplasia and cervical squamous cancer.
    Zhou JH; Chen HZ; Ye F; Lu WG; Xie X
    Oncol Rep; 2006 Aug; 16(2):307-11. PubMed ID: 16820908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
    Alshenawy HA
    Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.
    Yin G; Li J; Zhu T; Zhao X
    World J Surg Oncol; 2012 Aug; 10():168. PubMed ID: 22909227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions.
    Zheng X; Liang P; Zheng Y; Yi P; Liu Q; Han J; Huang Y; Zhou Y; Guo J; Li L
    Int J Gynecol Cancer; 2013 Jun; 23(5):785-90. PubMed ID: 23669440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SOX2 Expression in Cervical Intraepithelial Neoplasia Grade 3 (CIN3) and Superficially Invasive (Stage IA1) Squamous Carcinoma of the Cervix.
    Stewart CJ; Crook M
    Int J Gynecol Pathol; 2016 Nov; 35(6):566-573. PubMed ID: 26886477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study of Ki-67, c-erbB2 and cyclin D-1 expression in CIN-I, CIN-III and squamous cell carcinoma of the cervix.
    Carreras R; Alameda F; Mancebo G; García-Moreno P; Mariñoso ML; Costa C; Fusté P; Baró T; Serrano S
    Histol Histopathol; 2007 Jun; 22(6):587-92. PubMed ID: 17357088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry.
    Davidson B; Goldberg I; Gotlieb WH; Ben-Baruch G; Kopolovic J
    Eur J Obstet Gynecol Reprod Biol; 1998 Jan; 76(1):109-14. PubMed ID: 9481557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Importance of immunohistochemical studies in the diagnosis and the prognostic evaluation of cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Review].
    García-Tamayo J; Molina J; Blasco-Olaetxea E
    Invest Clin; 2009 Jun; 50(2):241-50. PubMed ID: 19662819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tenascin expression in intraepithelial neoplasia and invasive carcinoma of the uterine cervix.
    Iskaros BF; Koss LG
    Arch Pathol Lab Med; 2000 Sep; 124(9):1282-6. PubMed ID: 10975921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
    Zhao Q; He Y; Wang XL; Zhang YX; Wu YM
    Clin Transl Oncol; 2015 Aug; 17(8):620-31. PubMed ID: 25893434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of bcl-2 and bax in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
    Aletra C; Ravazoula P; Scopa C; Kounelis S; Sotiropoulou G; Kourounis G; Ladopoulos I; Bonikos D
    Eur J Gynaecol Oncol; 2000; 21(5):494-8. PubMed ID: 11198041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix.
    Chen G; He C; Li L; Lin A; Zheng X; He E; Skog S
    BMC Cancer; 2013 May; 13():249. PubMed ID: 23693054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
    Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.